Rakesh Dahiya
Monday, October 31, 2022
CDSCO Panel approves Tofacitinib Ointment 2% to Continue Clinical Trial Study
https://thehealthmaster.com/2022/10/30/cdsco-panel-approves-tofacitinib-ointment-2-to-continue-clinical-trial-study/
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment